Antibody therapy is a treatment option for several diseases, including multiple myeloma. The logic behind it is relatively simple: A target molecule is selected because of its expression on tumor cells, and the antibody delivers cytotoxic effects. Therapeutic results in multiple myeloma indicate that the anti-CD38 antibodies may have relevant immunotherapeutic properties.

Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma Immunotherapy

Malavasi, Fabio;Faini, Angelo Corso
2019-01-01

Abstract

Antibody therapy is a treatment option for several diseases, including multiple myeloma. The logic behind it is relatively simple: A target molecule is selected because of its expression on tumor cells, and the antibody delivers cytotoxic effects. Therapeutic results in multiple myeloma indicate that the anti-CD38 antibodies may have relevant immunotherapeutic properties.
2019
Inglese
Esperti anonimi
25
10
2946
2948
3
no
2 – prodotto con deroga d’ufficio (SOLO se editore non consente/non ha risposto)
2
03-CONTRIBUTO IN RIVISTA::03B-Review in Rivista / Rassegna della Lett. in Riv. / Nota Critica
reserved
262
info:eu-repo/semantics/article
Malavasi, Fabio; Faini, Angelo Corso
File in questo prodotto:
File Dimensione Formato  
2946.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 217.64 kB
Formato Adobe PDF
217.64 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1952251
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact